drugset / Trial / NCT00918866

A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure

NCT00918866

Phase 4 Completed 32 enrolled Lantheus Medical Imaging
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this clinical research is to learn if DEFINITY® 416 will cause any adverse effects during Right Heart Catheterization. This research was requested by the FDA.

Timeline

Start
2009-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent 10 unknown Intravenous